MARKET

ABEO

ABEO

Abeona Therapeut
NASDAQ
3.790
+0.180
+4.99%
Closed 20:05 09/22 EDT
OPEN
3.610
PREV CLOSE
3.610
HIGH
3.950
LOW
3.610
VOLUME
109.78K
TURNOVER
0
52 WEEK HIGH
5.80
52 WEEK LOW
2.190
MARKET CAP
93.82M
P/E (TTM)
-1.2533
1D
5D
1M
3M
1Y
5Y
Abeona Therapeut: Statement of changes in beneficial ownership of securities
Press release · 5d ago
Weekly Report: what happened at ABEO last week (0911-0915)?
Weekly Report · 6d ago
Weekly Report: what happened at ABEO last week (0904-0908)?
Weekly Report · 09/11 11:23
Weekly Report: what happened at ABEO last week (0828-0901)?
Weekly Report · 09/05 03:45
Abeona plans marketing submission for lead asset after FDA meeting
Seeking Alpha · 08/30 12:35
Abeona Therapeutics Plans To Proceed With BLA Submission To FDA For EB-101; Stock Up In Pre-market
NASDAQ · 08/30 12:11
Abeona Therapeutics Announces Positive Pre-BLA Meeting With FDA for EB-101 And Plans For BLA Submission
Benzinga · 08/30 11:33
Weekly Report: what happened at ABEO last week (0821-0825)?
Weekly Report · 08/28 11:30
More
About ABEO
Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing cell and gene therapies for life-threatening diseases. The Company’s lead clinical program is EB-101, an autologous, engineered cell therapy in development for recessive dystrophic epidermolysis bullosa (RDEB). Its development portfolio also features adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with unmet medical needs. The Company’s next generation AAV capsids are being evaluated to improve tropism profiles for a variety of devastating diseases. Its fully integrated cell and gene therapy Good Manufacturing Practice (cGMP) manufacturing facility produced EB-101 for the pivotal Phase III VIITAL study and is capable of clinical and potential commercial production of AAV-based gene therapies. EB-101 is an autologous, engineered cell therapy in which a functioning COL7A1 gene is inserted into a patient’s own skin cells (keratinocytes) using a retrovirus.

Webull offers kinds of Abeona Therapeutics Inc stock information, including NASDAQ:ABEO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ABEO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ABEO stock methods without spending real money on the virtual paper trading platform.